Want to join the conversation?
David Lim of Wells Fargo Securities asks whether $DLPH is seeing any kind of risk to North American production in 2H16. CFO Joe Massaro said the company is watching it very closely. He added that $DLPH has not had any updates or had not seen any softening at this point beyond the volume estimates that it has previously provided.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.